Safety and Effectiveness of an Internal Pelvic Myofascial Trigger Point Wand for Urological Chronic Pelvic Pain Syndrome

This prestigious recognition from the American Urological Association represents a major milestone in validating the trigger point wand as a legitimate medical device for treating chronic pelvic pain. Out of more than 2,000 research studies submitted to the AUA's 2011 conference, the internal trigger point wand study was selected as one of only 40 abstracts deemed important enough to present to the media and general public.

This honor is particularly significant because it means the wand - a key component of the Wise-Anderson Protocol (Stanford Protocol) - has undergone rigorous scientific review by leading urologists who confirmed it is both scientifically sound and newsworthy for patients suffering from chronic pelvic pain syndrome. The AUA's selection process specifically looks for research that will make a real difference in patients' lives.

For patients, this recognition means that the medical establishment is acknowledging what many have already discovered: that using a specially designed wand to release internal trigger points in the pelvic floor muscles can provide significant relief from chronic pelvic pain. This tool allows patients to perform self-treatment at home, giving them control over their recovery and reducing dependence on medications or frequent clinical visits. The AUA's endorsement helps legitimize this treatment approach and may encourage more healthcare providers to recommend it to their patients with chronic pelvic pain syndrome.